241 related articles for article (PubMed ID: 9236930)
21. Different proliferation patterns in breast cancer: AgNOR measurements in ER-negative and ER-positive tumor cells.
Günther L; Hufnagl P; Winzer KJ; Guski H
Anal Cell Pathol; 2000; 20(4):155-62. PubMed ID: 11205318
[TBL] [Abstract][Full Text] [Related]
22. AgNORs and their relationship to cell size, histological grade, lymph node involvement, metastases, and survival pattern in carcinoma of the breast: a study from south India.
Subramanian S; Shariff S; Andrade C
J Surg Oncol; 1996 Jun; 62(2):139-43. PubMed ID: 8649041
[TBL] [Abstract][Full Text] [Related]
23. Tumor proliferative fraction in infiltrating duct carcinoma.
Kesari AL; Chellam VG; Nair PP; Madhavan J; Nair P; Nair MK; Pillai MR
Gen Diagn Pathol; 1997 Dec; 143(4):219-24. PubMed ID: 9489954
[TBL] [Abstract][Full Text] [Related]
24. Correlation between AgNOR count and subjective AgNOR pattern assessment score in cytology and histology of breast lumps.
Khanna AK; Ansari MA; Kumar M; Khanna A
Anal Quant Cytol Histol; 2001 Dec; 23(6):388-94. PubMed ID: 11777272
[TBL] [Abstract][Full Text] [Related]
25. Value of AgNORS in fine needle aspiration cytology of breast lesions.
Rajeevan K; Aravindan KP; Kumari BC
Indian J Pathol Microbiol; 1995 Jan; 38(1):17-24. PubMed ID: 8919465
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage I breast cancer].
Ogawa Y; Chung YS; Nakata B; Takatsuka S; Maeda K; Sawada T; Kato Y; Yoshikawa K; Sowa M
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():66-70. PubMed ID: 7747994
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of nucleolar organiser regions (AgNORs) in laryngeal cancer.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Rak J; Szajowski K
Acta Otorhinolaryngol Belg; 1998; 52(3):215-21. PubMed ID: 9810456
[TBL] [Abstract][Full Text] [Related]
28. The relationship between clinical staging, oestrogen receptor status and silver-binding nucleolar organiser regions (AgNOR) in breast carcinoma.
Ohri AK; Ohri SK; Herbert A; Royle G; Taylor I
Eur J Surg Oncol; 1992 Apr; 18(2):103-7. PubMed ID: 1582501
[TBL] [Abstract][Full Text] [Related]
29. Nucleolar organizer regions in laryngeal cancer.
Klatka J; Skomra D
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():417-21. PubMed ID: 11977351
[TBL] [Abstract][Full Text] [Related]
30. Argyrophilic nucleolar organizer regions (AgNORs) in breast lesions--a study on fine needle aspirates.
Karmakar T; Radhika S; Gupta SK
Cytopathology; 1995 Feb; 6(1):5-13. PubMed ID: 7734703
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of argyrophilic nucleolar organizer region (AgNOR) staining in feline intestinal lymphoma.
Rassnick KM; Mauldin GN; Moroff SD; Mauldin GE; McEntee MC; Mooney SC
J Vet Intern Med; 1999; 13(3):187-90. PubMed ID: 10357106
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
[TBL] [Abstract][Full Text] [Related]
33. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
Nagatani T; Iemoto G; Miyakawa K; Ichiyama S; Takahashi Y; Uchiyama M; Nakajima H
J Dermatol; 1991 Dec; 18(12):731-5. PubMed ID: 1806604
[TBL] [Abstract][Full Text] [Related]
34. Expression of Fas and Fas-ligand and analysis of argyrophilic nucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and apoptosis.
Guler N; Uckan S; Celik I; Oznurlu Y; Uckan D
Int J Oral Maxillofac Surg; 2005 Dec; 34(8):900-6. PubMed ID: 15907374
[TBL] [Abstract][Full Text] [Related]
35. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
Chen M; Lee JC; Lo S; Shen J
Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of argyrophilic nucleolar organizer regions in nasopharyngeal carcinoma.
Pak MW; To KF; Leung SF; van Hasselt CA
Eur Arch Otorhinolaryngol; 2000 Nov; 257(9):517-20. PubMed ID: 11131381
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implication of silver-binding nucleolar organizer regions (AgNORs) in oral squamous cell carcinoma.
Sano K; Takahashi H; Fujita S; Inokuchi T; Pe MB; Okabe H; Tsuda N
J Oral Pathol Med; 1991 Feb; 20(2):53-6. PubMed ID: 1707972
[TBL] [Abstract][Full Text] [Related]
38. Morphometric evaluation of nucleolar organiser regions in reactive and neoplastic lymph node lesions.
Arora B; Kumar S; Jain R
J Indian Med Assoc; 2006 Jan; 104(1):16-8, 24. PubMed ID: 16850861
[TBL] [Abstract][Full Text] [Related]
39. A correlation of argyrophilic nucleolar organizer regions with stages of hepatocellular carcinoma.
Shiro T; Seki T; Naitoh Y; Inoue K; Okamura A
Cancer; 1993 Jan; 71(1):44-9. PubMed ID: 8380120
[TBL] [Abstract][Full Text] [Related]
40. The argyrophilic nucleolar organizer regions in ductal carcinoma in situ of the breast. The significance of ploidy and proliferative activity analysis using this silver staining technique.
Mourad WA; Setrakian S; Hales ML; Abdulla M; Trucco G
Cancer; 1994 Sep; 74(6):1739-45. PubMed ID: 8082076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
